Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome
Authors:
- Sonya KashyapSKSonya Kashyap
- George A. WellsGWGeorge A. Wells
- Zev RosenwaksZRZev Rosenwaks
Open Access
- 1 November 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 19 (11) , 2474-2483
Abstract
BACKGROUND: This paper is a systematic review of metformin versus clomiphene citrate (CC) in women with polycystic ovary syndrome (PCOS). METHODS: Meta-analysis Of Observational Studies in Epidemiology (MOOSE) and QUality Of Reporting Of Meta-analyses (QUOROM) guidelines were followed. A systematic computerized literature search was done of seven bibliographic databases. Inclusion criteria included cohort and randomized controlled trials (RCT) of women with PCOS and the following medications: metformin versus placebo; metformin versus CC; metformin plus CC versus placebo plus CC. Rev-man 4.1 and Metaview 4.0 were used to analyse data. Relative risk (RR) estimates were presented. A χ2-test determined the significance of the association. Heterogeneity was determined by the Cochran Q-test. RESULTS: Metformin was 50% better than placebo for ovulation induction in infertile PCOS patients [RR 1.50; 95% confidence interval (CI) 1.13, 1.99]. Metformin was also of benefit in non-infertile (i.e. patients with PCOS who were not complaining of infertility) PCOS patients for cycle regulation compared to placebo (RR 1.45; CI 1.11, 1.90). Metformin was not of confirmed benefit versus placebo for achievement of pregnancy (RR 1.07; CI 0.20, 5.74). Metformin plus CC may be 3-4-fold superior to CC alone for ovulation induction (RR 3.04; CI 1.77, 5.24) and pregnancy (RR 3.65; CI 1.11, 11.99) in women with PCOS. CONCLUSIONS: Metformin is effective for ovulation induction and cycle regulation in this group of patients. Metformin plus CC appears to be very effective for achievement of pregnancy compared to CC alone. No RCTs directly compare metformin to CC but the need for such a trial exists.Keywords
This publication has 38 references indexed in Scilit:
- Metformin in polycystic ovary syndrome: systematic review and meta-analysisBMJ, 2003
- Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practiceBritish Journal of Clinical Pharmacology, 2002
- Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndromeGynecological Endocrinology, 2002
- Increased pregnancy rates with metformin and clomiphene citrate in non-obese patients with polycystic ovary syndrome: prospective randomized study.Fertility and Sterility, 2001
- What contributions do languages other than English make on the results of meta-analyses?Journal of Clinical Epidemiology, 2000
- Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary SyndromeNew England Journal of Medicine, 1996
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Modern Aspects of Ovulation InductionAnnals of the New York Academy of Sciences, 1991
- Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.BMJ, 1986
- Ovulation and Pregnancy Rates With Clomiphene CitrateObstetrics & Gynecology, 1978